Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Sex-determining genes may affect male baldness.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Hirsutism causes significant psychological distress in women.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Finasteride affects SRD5A2 gene pattern, possibly causing lasting side effects.

DHT affects testicular development and regulates spermatogenesis in some fish.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Cytochrome P-450 enzymes in the skin help break down various substances and could be targeted to treat skin conditions.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Post-finasteride syndrome's existence is uncertain; more research needed.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Finasteride negatively affects fish reproduction and gonadal development.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.